EMD-48101

Single-particle
4.18 Å
EMD-48101 Deposition: 27/11/2024
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48101

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9eje summary report (pdf.gz) Map-9eje FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

NCS.1 Fab in complex with N5 NA of A/shorebird/Delaware Bay/309/2016 (DB16, H10N5) -- 3 Fabs

EMD-48101

Single-particle
4.18 Å
EMD-48101 Deposition: 27/11/2024
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Influenza A virus
Sample: NCS.1 Fab in complex with N5 NA of A/shorebird/Delaware Bay/309/2016 (DB16, H10N5) -- 3 Fabs
Fitted models: 9eje

Deposition Authors: Borst AJ
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies.
PUBMED: 40750617
DOI: doi:10.1038/s41467-025-62339-z
ISSN: 2041-1723
Grant Support: